Coronary heart disease secondary prevention influenza vaccination
|
Coronary heart disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Coronary heart disease secondary prevention influenza vaccination On the Web |
|
American Roentgen Ray Society Images of Coronary heart disease secondary prevention influenza vaccination |
|
FDA on Coronary heart disease secondary prevention influenza vaccination |
|
CDC on Coronary heart disease secondary prevention influenza vaccination |
|
Coronary heart disease secondary prevention influenza vaccination in the news |
|
Blogs on Coronary heart disease secondary prevention influenza vaccination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Influenza Vaccination
2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease (DO NOT EDIT) [1]
Influenza Vaccination (DO NOT EDIT) [1]
| Class I |
| "1. Patients with cardiovascular disease should have an annual influenza vaccination. [2][3][4][5] (Level of Evidence: B)" |
Sources
- 2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Aterosclerotic Vascular Disease (DO NOT EDIT) [1]
References
- ↑ 1.0 1.1 1.2 Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA; et al. (2011). "AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation". Circulation. 124 (22): 2458–73. doi:10.1161/CIR.0b013e318235eb4d. PMID 22052934.
- ↑ Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B (2004). "Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study". Eur. Heart J. 25 (1): 25–31. PMID 14683739. Unknown parameter
|month=ignored (help) - ↑ Ciszewski A, Bilinska ZT, Brydak LB; et al. (2008). "Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study". Eur. Heart J. 29 (11): 1350–8. doi:10.1093/eurheartj/ehm581. PMID 18187561. Unknown parameter
|month=ignored (help) - ↑ Davis MM, Taubert K, Benin AL; et al. (2006). "Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology". Circulation. 114 (14): 1549–53. doi:10.1161/CIRCULATIONAHA.106.178242. PMID 16982936. Unknown parameter
|month=ignored (help) - ↑ Lindsey NP, Staples JE, Lehman JA, Fischer M (2010). "Surveillance for human West Nile virus disease - United States, 1999-2008". MMWR Surveill Summ. 59 (2): 1–17. PMID 20360671. Unknown parameter
|month=ignored (help)